Health Condition 1: L210- Seborrhea capitis
Conditions
Interventions
Intervention1: MEERA anti dandruff powder is a 2 in 1 hair wash powder with small onion and Fenugreek with many natural herbs in it.: Two sachet of powder to be used for hair wash thrice weekly for 2
Sponsors
CavinKare Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male and female subjects who are 18 to 45 years of age. 2. Subjectssuffering from Dandruff of scalp 3. Subjects who are committed not to use medicated/non medicated shampoos/soaps (including soaps containing antibacterial/antifungal agents) or any other antidandruff treatment/hair products (including prescription and non-prescription medications such as hair oil, conditioners) for the entire duration of the study. 4. Subject usually using a shampoo 3 times a week and accepting to follow this rate during the whole study period. 5. Subjects not have participated in any other clinical trial during the past 3 months.
Exclusion criteria
Exclusion criteria: 1. Scalp Psoriasis. 2. Subjects who underwent any type of hair procedures within the past 2 weeks or during the study. 3. Subjects with immediate life threatening diseases such as pre-existing cardiovascular, liver or neoplastic disease. 4. Subjects undergoing treatment for immune-compromised conditions/psychiatric illness. 5. Subjects with any other co- morbid conditions like Diabetes that can affect the study outcome. 6. Pregnant or lactating women. 7. Hypersensitivity to any of the components of the test formulation. 8. The presence of any other condition that leads the investigator to conclude that the patient is inappropriate for inclusion in this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Total Dandruff Severity Score (TDSS) 2. Changes in the intensity of hair fall over 4 weeks from baseline to final treatment visit using Visual Analogue Scale (VAS) 3. Global improvement (self-assessment scoring& Photographs) by the subject. 4. Pull test ââ?¬â?? to evaluate the severity of hair shedding. Timepoint: Week 1, 2, 3 and 4 | — |
Secondary
| Measure | Time frame |
|---|---|
| To monitor for any adverse events during the study period and assess quality of lifeTimepoint: Week 1, 2, 3 and 4 | — |
Countries
India
Contacts
Public ContactDr M Sakthi Balan
KI3, CRO
Outcome results
None listed